Sian Fereday Selected Research

Carcinoma (Carcinomatosis)

1/2023	CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
1/2023	Profiling the immune landscape in mucinous ovarian carcinoma.
1/2023	Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
1/2020	Therapeutic options for mucinous ovarian carcinoma.
1/2019	Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.
11/2018	BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.
10/2018	Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
1/2018	Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.
1/2017	EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas.
6/2015	Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sian Fereday Research Topics

Disease

22	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 09/2008
21	Neoplasms (Cancer) 12/2023 - 08/2008
15	Carcinoma (Carcinomatosis) 01/2023 - 02/2009
5	Ovarian Epithelial Carcinoma 11/2023 - 01/2018
2	Endometriosis 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Residual Neoplasm 01/2020 - 09/2008
2	Endometrioid Carcinoma 08/2013 - 10/2010
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Nevus (Nevi) 01/2021
1	Turcot syndrome 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Overweight 04/2014
1	Obesity 04/2014

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 07/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2009
4	PlatinumIBA 01/2019 - 02/2009
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2019
3	Hormones (Hormone)IBA 01/2023 - 08/2013
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2008
2	ParaffinIBA 01/2023 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2023 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	ChromatinIBA 01/2021 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2008
2	taxaneIBA 01/2018 - 09/2008
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	CyclinsIBA 01/2023
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2023
1	Talc FDA Link 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	SmokeIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	CA-125 Antigen (CA 125 Antigen)IBA 11/2018
1	dabrafenibIBA 11/2018
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	TransducinIBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	Circulating Tumor DNAIBA 04/2017
1	Cell-Free Nucleic AcidsIBA 04/2017
1	Ligases (Synthetase)IBA 12/2016
1	UbiquitinIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2014
1	liposomal doxorubicin (Doxil)FDA Link 08/2012
1	OligonucleotidesIBA 02/2009
1	Differentiation AntigensIBA 08/2008
1	Cadherins (E-Cadherin)IBA 08/2008

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2023 - 09/2008
7	Therapeutics 01/2023 - 01/2013
1	Tubal Sterilization (Tubal Ligation) 01/2023
1	Cytoreduction Surgical Procedures 01/2023
1	Aftercare (After-Treatment) 01/2018
1	Neoadjuvant Therapy 09/2016
1	Combination Drug Therapy (Combination Chemotherapy) 05/2015